Guy Salama
Overview
Explore the profile of Guy Salama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
2739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Romero G, Martin B, Gabris B, Salama G
Biochem Pharmacol
. 2024 Jul;
227:116407.
PMID: 38969298
Healthy aging results in cardiac structural and electrical remodeling that increase susceptibility to cardiovascular diseases. Relaxin has shown broad cardioprotective effects including anti-fibrotic, anti-arrhythmic and anti-inflammatory outcomes in multiple models....
2.
Hayase J, Salama G
JACC Clin Electrophysiol
. 2024 Mar;
10(4):651-653.
PMID: 38520435
No abstract available.
3.
Gabris-Weber B, Forghani R, Dschietzig T, Romero G, Salama G
Biochem Pharmacol
. 2024 Mar;
223:116136.
PMID: 38494063
Relaxin-2 (RLX), a critical hormone in pregnancy, has been investigated as a therapy for heart failure. In most studies, the peptide was delivered continuously, subcutaneously for 2 weeks in animals...
4.
Michaely P, Bielinski S, Campbell K, DAlessio F, Dean D, Earley Y, et al.
J Clin Transl Sci
. 2023 Oct;
7(1):e215.
PMID: 37900348
The National Institutes of Health's (NIH) K99/R00 Pathway to Independence Award offers promising postdoctoral researchers and clinician-scientists an opportunity to receive research support at both the mentored and the independent...
5.
Zahid M, Weber B, Yurko R, Islam K, Agrawal V, Lopuszynski J, et al.
Pharmaceutics
. 2023 Aug;
15(8).
PMID: 37631321
Background: Amiodarone is underutilized due to significant off-target toxicities. We hypothesized that targeted delivery to the heart would lead to the lowering of the dose by utilizing a cardiomyocyte-targeting peptide...
6.
Yurko R, Islam K, Weber B, Salama G, Zahid M
Front Chem
. 2023 Aug;
11:1220573.
PMID: 37547910
Modern medicine has developed a myriad of therapeutic drugs against a wide range of human diseases leading to increased life expectancy and better quality of life for millions of people....
7.
Zahid M, Weber B, Yurko R, Islam K, Agrawal V, Lopuszynski J, et al.
bioRxiv
. 2023 May;
PMID: 37214919
Background: Amiodarone is underutilized due to significant off-target toxicities. We hypothesized that targeted delivery to the heart would lead to lowering of dose by utilizing a cardiomyocyte targeting peptide (CTP),...
8.
Choi B, Ziv O, Salama G
Front Cardiovasc Med
. 2023 May;
10:1158480.
PMID: 37153461
Background And Significance: The specialized conduction system (SCS) of the heart was extensively studied to understand the synchronization of atrial and ventricular contractions, the large atrial to His bundle (A-H)...
9.
Carew N, Schmidt H, Yuan S, Galley J, Hall R, Altmann H, et al.
J Clin Invest
. 2022 Sep;
132(18).
PMID: 36106636
Sudden cardiac death (SCD) in patients with heart failure (HF) is allied with an imbalance in reduction and oxidation (redox) signaling in cardiomyocytes; however, the basic pathways and mechanisms governing...
10.